Savitz Ryan
Insider CIK 1992324 · DNTH EVP, CFO & CBO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-07-09 | 2026-07-13 | 31,249 | — | $0 | 68,751 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-07-09 | 2026-07-13 | 15,329 | $101.24 | $1.55M | 5,566 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-07-09 | 2026-07-13 | 5,566 | $101.97 | $567.6K | 0 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-07-09 | 2026-07-13 | 10,354 | $100.22 | $1.04M | 20,895 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-07-09 | 2026-07-13 | 31,249 | $21.77 | $680.3K | 31,249 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-04-09 | 2026-04-10 | 8,224 | — | $0 | 71,776 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-04-09 | 2026-04-10 | 8,224 | $89.84 | $738.8K | 0 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-04-09 | 2026-04-10 | 8,224 | $17.88 | $147.0K | 8,224 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-03-31 | 2026-04-01 | 40,000 | — | $0 | 80,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-03-31 | 2026-04-01 | 74,367 | — | $0 | 10,399 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-03-31 | 2026-04-01 | 74,367 | $8.44 | $627.7K | 74,367 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-03-31 | 2026-04-01 | 40,000 | $17.88 | $715.2K | 114,367 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-31 | 2026-04-01 | 1,390 | $78.33 | $108.9K | 112,977 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-31 | 2026-04-01 | 7,232 | $85.54 | $618.6K | 0 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-31 | 2026-04-01 | 19,469 | $84.57 | $1.65M | 7,232 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-31 | 2026-04-01 | 59,800 | $83.90 | $5.02M | 26,701 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-31 | 2026-04-01 | 2,366 | $82.84 | $196.0K | 86,501 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-31 | 2026-04-01 | 800 | $81.36 | $65.1K | 88,867 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-31 | 2026-04-01 | 1,485 | $80.25 | $119.2K | 89,667 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-31 | 2026-04-01 | 21,825 | $78.86 | $1.72M | 91,152 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2026-02-03 | 2026-02-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2025-12-04 | 2025-12-05 | 20,000 | — | $0 | 84,766 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2025-12-04 | 2025-12-05 | 20,000 | $8.44 | $168.8K | 20,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2025-12-04 | 2025-12-05 | 20,000 | $45.18 | $903.6K | 0 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2025-09-23 | 2025-09-25 | 60,000 | — | $0 | 60,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2025-09-09 | 2025-09-11 | 20,000 | — | $0 | 104,766 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2025-09-09 | 2025-09-11 | 20,000 | $8.44 | $168.8K | 20,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2025-09-09 | 2025-09-11 | 20,000 | $35.00 | $700.0K | 0 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2025-02-03 | 2025-02-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2024-05-23 | 2024-05-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2024-01-24 | 2024-01-26 | 120,000 | — | $0 | 120,000 | SEC↗ |